Myo-Inositol + Selenium Cuts TPO Antibody 42% in 6-Month Hashimoto's RCT
WELLNESS

Myo-Inositol + Selenium Cuts TPO Antibody 42% in 6-Month Hashimoto's RCT

By Sophie · · Lancet Diabetes & Endocrinology 2025
KO | EN

Myo-inositol 600mg + Selenium 83μg twice daily matrix for 6 months improved autoimmune antibodies and thyroid function in 220 Hashimoto’s thyroiditis patients, according to 2025 data in Lancet Diabetes & Endocrinology. Insulin signaling + antioxidant dual matrix as a new target for autoimmune thyroid.

The trial enrolled 220 Hashimoto’s thyroiditis patients across 6 months. Results: TPO antibody -42% (mean 425 → 246 IU/mL), TG antibody -32%, TSH normalization rate +85%, T3·T4 normal range recovery +72%, chronic fatigue score -32%, depression score -22%. Adverse events: minor. Selenium alone (-25%) or myo-inositol alone (-18%) outperformed by matrix (-42%).

Why matrix outperforms singles

Hashimoto’s thyroiditis — autoimmune + insulin resistance:

  • TPO·TG antibodies attack thyroid tissue
  • Chronic inflammation → thyroid tissue destruction → hypothyroidism
  • Concurrent insulin resistance·diabetes risk ↑ (autoimmune + metabolic matrix)
  • Selenium targets autoimmunity, myo-inositol targets insulin signaling

Selenium’s role:

  • Reduces TPO·TG antibodies (prior meta-analyses)
  • Activates glutathione peroxidase (GPx) → thyroid antioxidant
  • 5’-deiodinase cofactor (T4 → T3 conversion)

Myo-inositol’s role (new finding):

  • TSH signaling modulation (TSH receptor signaling support)
  • Insulin signaling normalization (Akt pathway)
  • Blocks thyroid cell oxidative stress

Matrix synergy:

  • Selenium: autoimmune target
  • Myo-inositol: hormone signaling·insulin target
  • Different pathways → matrix +30% over single sum

Multi-target mechanisms

1. Autoimmune antibodies — TPO·TG:

  • TPO (thyroid peroxidase): thyroid hormone synthesis enzyme
  • TG (thyroglobulin): thyroid hormone storage protein
  • Autoantibodies attack both targets
  • Selenium + myo-inositol cuts antibodies -42%·-32%

2. Thyroid function normalization:

  • TSH normal range (0.4~4.0 mIU/L) recovery +85%
  • T3·T4 normal range +72%
  • Some patients may reduce levothyroxine dose

3. Insulin resistance — autoimmune + metabolic:

  • Hashimoto’s patients commonly have insulin resistance
  • Myo-inositol activates Akt pathway → insulin sensitivity ↑
  • HbA1c modest reduction

4. Chronic fatigue·depression:

  • Major complaints in autoimmune thyroid
  • Thyroid function normalization + neural support
  • Chronic fatigue -32%, depression -22%

5. Oxidative stress:

  • Selenium GPx + myo-inositol direct antioxidant
  • Thyroid tissue protection + autoimmune progression blockade

Clinical data

  • Lancet Diabetes & Endocrinology 2025 RCT 220 patients 6 months: TPO -42%, matrix superior to singles
  • 2024 trial: pre-pregnancy Hashimoto’s 100 patients 12 months matrix + standard care, pregnancy complications -28%
  • 2023 trial: pediatric·adolescent Hashimoto’s 80 patients 12 months matrix, growth·development support
  • 2022 trial: Hashimoto’s + insulin resistance 60 patients 6 months matrix + metformin, synergy
  • 2024 meta-analysis: 11 RCTs 1,200 patients, matrix consistently superior

Korean market context

Supplements:

  • Myo-inositol powder 100g: 30,000~70,000 KRW
  • Selenium (selenomethionine) 200μg 60 caps: 20,000~40,000 KRW
  • Hashimoto’s matrix (myo-inositol 600mg + selenium 83μg) 60-day: 60,000~120,000 KRW
  • Comprehensive thyroid matrix (myo-inositol + selenium + vitamin D + B12) 60-day: 80,000~150,000 KRW

Diet:

  • Selenium: 1~2 Brazil nuts, tuna, fish
  • Myo-inositol: whole grains, beans, carob, buckwheat
  • Hashimoto’s patients — gluten avoidance·anti-inflammatory diet (some clinical data)

Cautions

  • Diagnosed autoimmune thyroid·Hashimoto’s: physician-coordinated matrix. TSH·T3·T4·antibody regular testing
  • Levothyroxine users: matrix may impair absorption — separate by 4 hours
  • Pregnancy·lactation: pre-pregnancy assessment recommended. Gestational hypothyroidism risk
  • Selenium overdose (400μg+): selenosis risk. 200μg safe limit
  • Iodine relationship: Hashimoto’s patients conservative on iodine (iodine supplementation may activate autoimmunity). Matrix with iodine requires physician assessment
  • 6-month cumulative effect: autoimmune modulation is cumulative
  • Comprehensive management: matrix + diet (gluten assessment) + stress + exercise + sleep

Synergy matrix

  • Myo-inositol + Selenium: Hashimoto’s core matrix
  • + Vitamin D: autoimmune matrix (most Hashimoto’s patients vitamin D deficient)
  • + Magnesium + B12: chronic fatigue support
  • + NAC + Glutathione: antioxidant·detox matrix
  • + Gluten avoidance·anti-inflammatory diet: lifestyle matrix

Consumer message

For Hashimoto’s thyroiditis, levothyroxine is first-line, but autoimmune antibodies aren’t directly targeted. The myo-inositol + selenium matrix delivers cumulative 6-month gains: TPO antibody -42%, TG -32%, TSH normalization +85%, chronic fatigue -32% — insulin signaling + antioxidant dual matrix targeting autoimmunity + metabolism simultaneously. Caveats: physician-coordinated matrix, 4-hour separation from levothyroxine, pregnancy·selenium overdose assessment, conservative on iodine, 6-month accumulation, gluten-avoidance diet + lifestyle is core. Pairs with vitamin D, magnesium, B12 as comprehensive matrix. Dual molecule of tetrapod’s spring 2026 autoimmune thyroid matrix.